Corbus Pharmaceuticals Holdings, Inc.

Ownership Transactions Reported by 14 Insiders

Symbol
CRBP on Nasdaq
Location
500 River Ridge Drive, Norwood, MA

Insiders trading volume in the past year

Corbus Pharmaceuticals Holdings, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Cormorant Asset Management, LP 10%+ Owner $52.8M +$20.1M +61.4% Sep 20, 2024
Rachael Brake Chief Scientific Officer $6.96M Feb 13, 2023
Craig Millian Chief Operating Officer $4.65M Feb 13, 2023
Yuval Cohen Chief Executive Officer, Director $3.54M -$2.95M -45.4% Jun 14, 2024
Sean Moran Chief Financial Officer $3.51M -$864K -19.8% Jun 14, 2024
Dominic Smethurst Chief Medical Officer $1.75M Feb 27, 2024
Alan Holmer Director $182K Jun 14, 2024
Winston Kung Director $167K Aug 16, 2024
Avery Catlin Director $144K May 30, 2024
John Jenkins Director $98.3K May 30, 2024
Yong Ben Director $97.3K May 30, 2024
Anne Altmeyer Director $97.3K May 30, 2024
Peter Salzmann Director $97.3K May 30, 2024
Rachelle Suzanne Jacques Director $97.3K May 30, 2024

Recent Insider Transactions by Companies or Individuals for Corbus Pharmaceuticals Holdings, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.